Machine learning prognostic model and drug survival analysis for lung adenocarcinoma in the context of radiotherapy.
BACKGROUND Patients with lung adenocarcinoma (LUAD) receiving radiotherapy represent an important but underexplored clinical subgroup. These patients often undergo concomitant pharmacologic treatments, yet the prognostic impact and underlying determinants of such combined regimens remain poorly understood. OBJECTIVE...